Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

A man who lost over three stone in as many months via the weight loss medicine Mounjaro has admitted to making a 'big mistake ...

A new expert review endorses GLP-1 RAs and other medications for sustainable weight loss in children with obesity and MASLD.

A man who lost over three stone in as many months via the weight loss medicine Mounjaro has admitted to making a 'big mistake ...

Despite the current downward trend, long-term investors may stay invested in NVO stock due to strong demand for its GLP-1 ...

AFTER “fighting a losing battle” with her weight for years, a mum shed 11st in a matter months with the help of weight loss ...

The first trial, PIONEER 4, set the new drug against Novo’s own product, injectable once a week Victoza. Semaglutide performed better than expected against Victoza. The results included ...

Dispensations of tirzepatide and semaglutide increased significantly in recent years while the use of other glucose-lowering ...

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against ...

Weight loss injections boost the glucagon-like peptide-1 (GLP-1) hormone, which is a naturally produced hormone in the ...

A WOMAN who weighed 12st 10lbs and was a size 16 decided to try the weight loss jab after struggling to stick to diets, but things weren’t as perfect as she’d hoped. Kathleen Smith, ...